NRC National Research Corp

Price (delayed)

$31.15

Market cap

$743.78M

P/E Ratio

24.92

Dividend/share

$0.48

EPS

$1.25

Enterprise value

$784.15M

NRC Health is the leading provider of in-depth customer insights in healthcare.

Highlights
The stock's price to earnings (P/E) is 28% less than its last 4 quarters average of 34.4 and 27% less than its 5-year quarterly average of 34.2
The EPS has grown by 2.5% year-on-year
National Research's debt has surged by 100% YoY and by 15% QoQ
The quick ratio has dropped by 75% year-on-year and by 51% since the previous quarter

Key stats

What are the main financial stats of NRC
Market
Shares outstanding
23.88M
Market cap
$743.78M
Enterprise value
$784.15M
Valuations
Price to book (P/B)
20.11
Price to sales (P/S)
5.04
EV/EBIT
19.42
EV/EBITDA
16.93
EV/Sales
5.32
Earnings
Revenue
$147.42M
EBIT
$40.37M
EBITDA
$46.32M
Free cash flow
$25.68M
Per share
EPS
$1.25
Free cash flow per share
$1.08
Book value per share
$1.55
Revenue per share
$6.18
TBVPS
$2.42
Balance sheet
Total assets
$120.91M
Total liabilities
$83.97M
Debt
$42.07M
Equity
$36.95M
Working capital
-$28.84M
Liquidity
Debt to equity
1.14
Current ratio
0.41
Quick ratio
0.26
Net debt/EBITDA
0.87
Margins
EBITDA margin
31.4%
Gross margin
62.3%
Net margin
20.6%
Operating margin
27%
Efficiency
Return on assets
24.4%
Return on equity
54.8%
Return on invested capital
93.4%
Return on capital employed
56%
Return on sales
27.4%
Dividend
Dividend yield
1.54%
DPS
$0.48
Payout ratio
38.4%

NRC stock price

How has the National Research stock price performed over time
Intraday
-0.67%
1 week
-0.45%
1 month
-8.46%
1 year
-27.78%
YTD
-21.26%
QTD
-21.36%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$147.42M
Gross profit
$91.83M
Operating income
$39.79M
Net income
$30.37M
Gross margin
62.3%
Net margin
20.6%
NRC's operating income is down by 9% YoY
National Research's operating margin has decreased by 8% YoY

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
P/E
24.92
P/B
20.11
P/S
5.04
EV/EBIT
19.42
EV/EBITDA
16.93
EV/Sales
5.32
The stock's price to earnings (P/E) is 28% less than its last 4 quarters average of 34.4 and 27% less than its 5-year quarterly average of 34.2
The EPS has grown by 2.5% year-on-year
National Research's equity has shrunk by 51% YoY and by 25% QoQ
NRC's price to book (P/B) is 12% less than its 5-year quarterly average of 22.9 but 3.1% more than its last 4 quarters average of 19.5
The P/S is 39% lower than the 5-year quarterly average of 8.3 and 27% lower than the last 4 quarters average of 6.9

Efficiency

How efficient is National Research business performance
NRC's return on invested capital is down by 36% year-on-year and by 11% since the previous quarter
NRC's return on equity is up by 28% year-on-year and by 15% since the previous quarter
The return on assets has increased by 8% year-on-year

Dividends

What is NRC's dividend history
DPS
$0.48
Dividend yield
1.54%
Payout ratio
38.4%
Recent dividends

Financial health

How did National Research financials performed over time
NRC's total assets is 44% greater than its total liabilities
The quick ratio has dropped by 75% year-on-year and by 51% since the previous quarter
NRC's current ratio has shrunk by 67% YoY and by 39% QoQ
National Research's debt is 14% higher than its equity
National Research's debt has surged by 100% YoY and by 15% QoQ
NRC's debt to equity has soared by 52% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.